Login/Sign Up
Bigspas-P Tablet 10's
₹86.9*
MRP ₹96.5
10% off
₹82.02*
MRP ₹96.5
15% CB
₹14.48 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Bigspas-P Tablet is a combination drug primarily used to reduce abdominal pain caused due to dysmenorrhoea (irregular periods/menses). Dysmenorrhea (Abdominal cramps) is an unpleasant sensory and emotional experience associated with irregular periods. It occurs just before or during menses. Menstrual cramps cause throbbing pain in the lower belly (abdomen) during menses. These cramps can range from mild to severe.
Bigspas-P Tablet is composed of two medicines: Camylofin (antispasmodic) and Paracetamol (analgesic). Paracetamol has both analgesic (pain reducer) and antipyretic (fever reducer) properties and decreases inflammation caused due to dysmenorrhea. It blocks a chemical messenger in pain responsible for making a person sense pain. Camylofin helps block the activity of certain natural substances in the body to cause pain. Together, they effectively reduce pain.
Bigspas-P Tablet should be taken as prescribed by the doctor. Bigspas-P Tablet is generally safe to consume. Some people may experience dizziness, nausea (feeling sick), digestion problems (constipation, flatulence, diarrhoea), and skin reactions (like rashes and hives). Most of the side effects of Bigspas-P Tablet do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Taking more than the daily prescribed dose of Bigspas-P Tablet may cause liver damage or allergic reactions like mouth, face, and throat swelling, difficulty breathing, skin rash, or itching. Most liver injury cases are associated with paracetamol at doses exceeding 4 gm per day. Gastrointestinal bleeding and ulcer formation are commonly observed with the help of Bigspas-P Tablet , so the doctor may prescribe you the lowest dose available.
Bigspas-P Tablet is composed of two medicines: Camylofin (antispasmodic) and Paracetamol (analgesic). Paracetamol has both analgesic (pain reducer) and antipyretic (fever reducer) properties and decreases inflammation caused due to dysmenorrhea. It blocks a chemical messenger in pain that is responsible for making a person sense pain. Camylofin helps block the activity of certain natural substances in the body to cause pain. Together, they effectively reduce pain.
Taking more than the daily prescribed dose of Bigspas-P Tablet may cause liver damage or allergic reactions like mouth, face, and throat swelling, difficulty breathing, skin rash, or itching. Do not take Bigspas-P Tablet if you have asthma or allergies to painkillers, heart, kidney, and liver conditions. Bigspas-P Tablet should not be taken during pregnancy or by breastfeeding mothers as it may affect the baby. You are recommended not to take alcohol along with Bigspas-P Tablet to avoid unpleasant side effects. Taking Bigspas-P Tablet can cause drowsiness or blurred vision; avoid driving or performing any other activity that requires concentration after taking Bigspas-P Tablet . Always keep your doctor informed about the ongoing medications or the ones you have taken in the past, including over-the-counter medicines and herbal medicines. Life-threatening skin allergic reactions like Stevens-Johnson syndrome (SJS) and Toxic epidermal necrolysis (TEN) have been reported using Paracetamol. If you observe skin rashes or blister formation, immediately stop taking Bigspas-P Tablet and consult a doctor. Patients taking Bigspas-P Tablet and antivitamin K (blood thinners) should be monitored for appropriate coagulation and bleeding complications.
Drug-Drug Interactions: Bigspas-P Tablet interact with antidepressant medicines (Amantadine), blood thinner (warfarin), anti-cancer or anti-arthritis drugs (methotrexate), medicines for treating tuberculosis (isoniazid and rifampicin) may lead to drug toxicity or affect the working of Bigspas-P Tablet . So, contact a doctor before taking these medicines.
Drug-Food Interactions: Intake of alcohol should be avoided while taking Bigspas-P Tablet .
Drug-Disease Interactions: Patients with liver disease, bleeding disorder, urinary tract infection (UTI), myasthenia gravis, high blood pressure, and alcoholism should not take the Bigspas-P Tablet as it has severe interaction.
Dysmenorrhea: Dysmenorrhea refers to abdominal cramps/pain and an unpleasant sensory/emotional experience associated with irregular periods. It occurs just before or during menses. Menstrual cramps that cause throbbing pain in the lower belly during periods may vary from mild to severe. Some of the common symptoms of menstrual cramps include an aching pain in your belly (sometimes painful), a feeling of pressure in your belly, and pain in your hips, lower back, and inner thighs.
Alcohol
Caution
You are recommended not to consume alcohol along with Bigspas-P Tablet as it contains paracetamol, which can together damage your liver severely.
Pregnancy
Caution
Bigspas-P Tablet should be used during pregnancy only if the potential benefit outweighs the potential risk to the fetus.
Breast Feeding
Caution
Bigspas-P Tablet should not be used if you are breastfeeding. Bigspas-P Tablet passes into breast milk, so it is not recommended for use during breastfeeding unless considered essential by your doctor.
Driving
Caution
Bigspas-P Tablet may cause dizziness, drowsiness, and visual disturbances, affecting their ability to drive or operate machinery. Make sure you are not affected before driving or operating machinery.
Liver
Caution
Bigspas-P Tablet to be taken with caution, especially if you have a history of Liver diseases/conditions. The dose may have to be adjusted by your doctor.
Kidney
Caution
Bigspas-P Tablet to be taken with caution, especially if you have a history of Kidney diseases/conditions. The dose may have to be adjusted by your doctor.
Children
Unsafe
Bigspas-P Tablet is not to be used in children below 12 years of age.
Country of origin
Manufacturer/Marketer address
Product Substitutes